bleeding complications ( lmw heparin : 14.9 % , uf heparin : 15.3 % ) and thromboembolic events ( lmw heparin : 2.86 % , uf heparin : 2.94 % ) were equal among the two groups .
C0019139
lmw heparin
C0019134
uf heparin